Search results
Results from the Tech24 Deals Content Network
Novavax stock ( NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi ( SNY) would invest $1.2 billion in a deal for Novavax's COVID-19 vaccine and take a ...
Novavax stock ( NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...
In a statement to Yahoo Finance, Novavax said they had recently provided updated manufacturing information to the FDA. "Novavax submitted its CMC data package on December 31 and applied for EUA on ...
Novavax, Inc. Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During ...
May 24, 2024 at 8:15 AM. Shares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3% ...
By Patrick Wingrove and Bhanvi Satija (Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that ...
May 19, 2024 at 8:49 AM. Vaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business ...
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.